| Erica Marie Cusick, PHARMD | |
|
28800 Dequindre Rd, Warren, MI 48092-2466 | |
| (586) 453-6584 | |
| Not Available |
| Full Name | Erica Marie Cusick |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 28800 Dequindre Rd, Warren, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033406699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302034928 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erica Marie Cusick, PHARMD 28800 Dequindre Rd, Warren, MI 48092-2466 Ph: () - | Erica Marie Cusick, PHARMD 28800 Dequindre Rd, Warren, MI 48092-2466 Ph: (586) 453-6584 |
News Archive
Vital Images, Inc., a leading provider of advanced visualization and analysis software for healthcare providers, today announced Vitrea® Enterprise Suite (VES) has achieved VMware Ready™ status. This designation indicates that VES has passed a detailed evaluation and testing process managed by VMware and is now listed on the VMware Partner Product Catalog.
Neurofibromatosis, a genetic disorder that causes tumors to grow on nerves throughout the body and which affects 1 in 3,000 people - that's over 2.5 million worldwide - has no cure and few workable treatment options.
The 2009 Monitoring the Future Survey released today by the National Institute of Drug Abuse shows that the nation continues to make gradual progress in reducing youth smoking, but declines have slowed significantly compared to the dramatic gains early in the decade. In especially troubling news, the survey also finds that smokeless tobacco use has increased among 10th and 12th graders in recent years, a period during which tobacco companies have introduced a slew of new smokeless tobacco products and significantly increased marketing for smokeless tobacco.
Scientists at The Scripps Research Institute have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus.
Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).
› Verified 2 days ago
Ms. Joslyn Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27472 Schoenherr Rd, Warren, MI 48088 Phone: 586-582-7800 | |
Dennis Raymond O'donnell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22835 Van Dyke, Warren, MI 48089 Phone: 586-757-6505 Fax: 586-757-7785 | |
Peter Lewyckyj, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31700 Van Dyke Ave., St John Pharmacy, Suite 190, Warren, MI 48093 Phone: 586-276-8000 | |
Sharad Kumar Chauhan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31111 Schoenherr Rd, Warren, MI 48088 Phone: 586-276-4501 | |
Larry Joseph Hinchey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13201 Stephens Rd, Suite B, Warren, MI 48089 Phone: 877-899-6337 Fax: 877-899-6360 | |
Mr. Mark Bomia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31700 Van Dyke Ave, Suite 190, Warren, MI 48093 Phone: 586-276-8040 Fax: 586-276-8039 |